Teufelsbauer Maryana, Stickler Sandra, Hammond Dennis C, Hamilton Gerhard
Clinics of Plastic and Reconstructive Surgery, Medical University of Vienna, 1090, Vienna, Austria.
Institute of Pharmacology, Medical University of Vienna, Waehringerstraße 13a, 1090, Vienna, Austria.
Aesthetic Plast Surg. 2024 Dec 10. doi: 10.1007/s00266-024-04587-w.
Fat grafting is frequently employed in aesthetic and reconstructive plastic surgery with a low complication rate. However, fat necrosis may occur in dependence of the mode of fat aspiration, processing of the tissue and graft size. Graft survival is critically dependent on the contained adipose-derived stromal cells (ADSCs), adipocyte precursors and their potential for vascular supply. This work investigated the potential role of the expression of vascular endothelial growth factor A (VEGF) and various cytokines by ADSCs and differentiated adipocytes as key factors of fat grafting.
Adipokine expression of ADSCs and differentiated adipocytes were assessed using Proteome Profiler Arrays that detect 58 relevant proteins.
Collected fat grafts could be categorized according to their adipokine expression into VEGF and VEGF ADSCs groups, the former exhibiting higher content of VEGF-related angiopoietin-like 2, nidogen-1/entactin, CCL2/MCP-1 and elevated expression of IGFBPs in association with a fourfold higher VEGF expression. Differentiation of ADSCs into adipocytes increased VEGF concentrations in VEGF ADSCs but not in ADSCs exhibiting initial high VEGF concentrations. The adipocytes revealed high expression of HGF, leptin, CCL2/MCP-1, nidogen-1/entactin, M-CSF but lower induction of angiopoietin-like 2.
Half of the ADSCs from fat grafts express high concentrations of VEGF and other adipokines that support angiogenesis and survival of this tissues following transfer. Differentiation of ADSC cells to adipocytes may make up for the initially low VEGF expression, but this activation is 7-10 days delayed compared to the VEGF ADSC cells and may fail to support angiogenesis from the beginning.
This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
脂肪移植常用于美容整形手术和重建整形手术,并发症发生率较低。然而,脂肪坏死可能因脂肪抽吸方式、组织处理和移植大小而发生。移植脂肪的存活严重依赖于其中所含的脂肪来源基质细胞(ADSCs)、脂肪细胞前体及其血管供应潜力。本研究调查了ADSCs和分化脂肪细胞中血管内皮生长因子A(VEGF)及多种细胞因子的表达作为脂肪移植关键因素的潜在作用。
使用可检测58种相关蛋白的蛋白质组分析芯片评估ADSCs和分化脂肪细胞的脂肪因子表达。
收集的脂肪移植组织可根据其脂肪因子表达分为VEGF组和VEGF ADSCs组,前者VEGF相关的血管生成素样蛋白2、巢蛋白-1/内动蛋白、CCL2/MCP-1含量较高,胰岛素样生长因子结合蛋白表达升高,且VEGF表达高出四倍。ADSCs向脂肪细胞的分化增加了VEGF ADSCs组中的VEGF浓度,但对初始VEGF浓度较高的ADSCs组则无此作用。脂肪细胞显示出较高的肝细胞生长因子、瘦素、CCL2/MCP-1、巢蛋白-1/内动蛋白、巨噬细胞集落刺激因子表达,但血管生成素样蛋白2诱导较低。
脂肪移植组织中一半的ADSCs表达高浓度的VEGF和其他支持血管生成及移植后组织存活的脂肪因子。ADSC细胞向脂肪细胞的分化可能弥补最初较低的VEGF表达,但这种激活比VEGF ADSC细胞延迟7至10天,且可能无法从一开始就支持血管生成。
本杂志要求作者为每篇适用循证医学排名的投稿指定证据水平。这排除了综述文章、书评以及涉及基础科学、动物研究、尸体研究和实验研究的手稿。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南www.springer.com/00266 。